Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Injuries prompt recall of Medtronic insulin sets:

This article was originally published in Clinica

Executive Summary

Medtronic is recalling its Quick-set Plus insulin infusion sets for diabetics in the US after a number of serious injuries and hospitalisations. Bending of the cannula and accidental disconnection at the insertion site causing interruption to the flow of insulin have been reported. The recall has been defined as class I by the FDA, meaning there is "a reasonable probability that the use of the product will cause serious adverse health consequences or death". In March, the company gave customers a tips guide for using the device, and offered replacement sets on request, following increased number of complaints. Medtronic has stopped selling Quick-set Plus sets.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058548

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel